Cite

    Olden, K. et al. (2019). Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome. Current medical research and opinion. pp. 461-472. [Online].